« Previous
Next »
Titles
- General clinical pharmacology considerations for neonatal studies for drugs and biological products1
- General considerations for animal studies intended to evaluate medical devices: guidance for industry and Food and Drug Administration staff1
- General principles for evaluating the abuse deterrence of generic solid oral opioid drug products1
- General principles for evaluating the human food safety of new animal drugs used in food-producing animals1
- Generic Drug User Fee Amendments of 2012: questions and answers related to self-identification of facilities, review of generic drug submissions, and inspections and compliance1
- Generic drug development: stakeholders’ views of risk evaluation and mitigation strategies differ : report to the Chairman, Committee on Energy and Commerce, House of Representatives1
- Generic drug user fees: application review times declined, but FDA should develop a plan for administering its unobligated user fees : report to the Chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate1
- Generic drugs: FDA should make public its plans to issue and revise guidance on nonbiological complex drugs : report to Congressional requesters1
- Generic drugs: Stakeholder views on improving FDA’s information on patents : report to congressional committees1
- Geographic disparities affect access to buprenorphine services for opioid use disorder1
- Geographic expansion of Medicaid managed care organizations: assessing access to primary care in nonmetropolitan counties1
- Georgia could better ensure that nursing homes comply with federal requirements for life safety, emergency preparedness, and infection control1
- Global health security: USAID and CDC funding, activities, and assessments of countries’ capacities to address infectious disease threats before COVID-19 onset : report to Congressional committees1
- Good manufacturing practice considerations for responding to COVID-19 infection in employees in drug and biological products manufacturing1
- Graduate medical education: programs and residents increased during transition to single accreditor; distribution largely unchanged : report to Congressional requesters1
- Guaranteeing integrated care for dual eligible individuals1
- Gulf War illness: additional actions needed to improve VA's claims process : testimony before the Subcommittees on Oversight and Investigations and Disability Assistance and Memorial Affairs, Committee on Veterans' Affairs, House of Representatives1
- Gulf War illness: improvements needed for VA to better understand, process, and communicate decisions on claims : report to Congressional requesters1